| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41418-020-0576-2 |
| P698 | PubMed publication ID | 32555451 |
| P50 | author | David C Huang | Q56987660 |
| P2093 | author name string | Zhen Xu | |
| Andreas Strasser | |||
| Silvia Alvarez-Diaz | |||
| David H Segal | |||
| Ming-Yuan Gao | |||
| Rachel Thijssen | |||
| Clea Grace | |||
| P2860 | cites work | Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells | Q33800218 |
| Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics | Q35686077 | ||
| Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death | Q36347249 | ||
| Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy | Q37078968 | ||
| Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53 | Q37488736 | ||
| The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models | Q38736457 | ||
| Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death | Q39462162 | ||
| The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs | Q39511129 | ||
| Loss of caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis. | Q41023161 | ||
| Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia | Q60045467 | ||
| P577 | publication date | 2020-06-18 | |
| P1433 | published in | Cell Death & Differentiation | Q2943974 |
| P1476 | title | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
Search more.